Targeted therapies: pazopanib for soft-tissue sarcoma: a PALETTE of data emerges (Q47429249)

16 January 2018

title

Targeted therapies: pazopanib for soft-tissue sarcoma: a PALETTE of data emerges (English)

1 reference

16 January 2018

1

Isabelle Ray-Coquard

1 reference

16 January 2018

author name string

David Thomas

series ordinal

2

1 reference

16 January 2018

language of work or name

English

0 references

publication date

3 July 2012

1 reference

16 January 2018

Nature Reviews Clinical Oncology

published in

1 reference

16 January 2018

volume

9

1 reference

16 January 2018

issue

8

1 reference

16 January 2018

page(s)

431-432

1 reference

16 January 2018

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.113

10.1038/NRCLINONC.2012.113

21 January 2018

Identifiers

DOI

1 reference

16 January 2018

1 reference

16 January 2018